The FTSE 100 Futures is trading at 7,392.00 with a loss of -0.01% percent or -1.00 point. The CAC 40 Futures is trading at 5,526.50 with a loss of -0.14% percent or -7.50 point. The DAX Futures is trading at 12,317.50 with a loss of -0.26% percent or -31.80 point. The EURO Stoxx 50 Futures trading at 3,438.00 with a loss of -0.23% percent or -8.00 point.
TODAY’S FACTORS AND EVENTS
AstraZeneca’s ovarian cancer drug Lynparza on Monday received an endorsement from the European Medicines Agency, where a committee approved it to be used as a first-line maintenance treatment.
The Committee for Medicinal Products for Human Use (CHMP) recommended the use of the drug specifically in cases of advanced ovarian cancer with a mutation in the BRCA gene following completion of first-line platinum-based chemotherapy.
The decision to endorse the treatment followed the Phase III SOLO-1 trial which showed that Lynparza, which is being jointly developed and commercialised by AstraZeneca and Merck, reduced the risk of disease progression or death by 70% against a placebo following response to platinum-based chemotherapy.
PREVIOUS DAY ACTIVITY
For the day the Dow is trading at 26,554.39 up with +0.042% percent or +11.06 point. The S&P 500 is trading at 2,943.03 up with +0.11% percent or +3.15 point. The Nasdaq Composite is trading at 8,161.85 up with +0.19% percent or +15.46 point.
In other parts of world, Japan’s Nikkei 225 is trading at 22,258.73 with a loss of -0.22% percent or -48.85 point. Hong Kong’s Hang Seng is trading at 29,705.32 with a loss of -0.63% percent or -187.49 point. China’s Shanghai Composite is trading at 3,078.34 up with +0.52% percent or +15.84 point. India’s BSE Sensex is trading at 38,887.18 with a loss of -0.46% percent or -180.15 point at 12:15 PM.